ロード中...
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
GSK3α has been identified as a new target in the treatment of acute myeloid leukemia (AML). However, most GSK3 inhibitors lack specificity for GSK3α over GSK3β and other kinases. We have previously shown in lung cancer cells that GSK3α and to a lesser extent GSK3β are inhibited by the advanced clini...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6345777/ https://ncbi.nlm.nih.gov/pubmed/30679640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-37174-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|